BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20498219)

  • 1. Treatment of rheumatoid arthritis: strategies for achieving optimal outcomes.
    Gibofsky A; Yazici Y
    Ann Rheum Dis; 2010 Jun; 69(6):941-2. PubMed ID: 20498219
    [No Abstract]   [Full Text] [Related]  

  • 2. [Administration of rituximab in rheumatoid arthritis from the position of evidence-based medicine].
    Nasonov EL
    Ter Arkh; 2007; 79(12):76-82. PubMed ID: 18220039
    [No Abstract]   [Full Text] [Related]  

  • 3. Guidelines for monitoring of methotrexate therapy: "evidence-based medicine" outside of clinical trials.
    Pincus T
    Arthritis Rheum; 2003 Oct; 48(10):2706-9. PubMed ID: 14558072
    [No Abstract]   [Full Text] [Related]  

  • 4. Is leflunomide as safe and effective in the treatment of rheumatoid arthritis as other DMARDs?
    Schooff M; Wickersham J
    Am Fam Physician; 2003 Sep; 68(5):849-50. PubMed ID: 13678131
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of biologic agents in rheumatoid arthritis: introduction.
    Silman AJ
    Rheumatology (Oxford); 2011 Sep; 50 Suppl 4():iv3-4. PubMed ID: 21859703
    [No Abstract]   [Full Text] [Related]  

  • 6. Do we still miss the chance of effectively treating early rheumatoid arthritis? New answers from a new study.
    Kary S; Fritz J; Scherer HU; Burmester GR
    Rheumatology (Oxford); 2004 Jul; 43(7):819-20. PubMed ID: 15187247
    [No Abstract]   [Full Text] [Related]  

  • 7. Hotel-based rheumatology, and more.
    Leeb BF
    J Rheumatol; 2009 Feb; 36(2):455-6; author reply 456-7. PubMed ID: 19208582
    [No Abstract]   [Full Text] [Related]  

  • 8. Unresolved issues in identifying and overcoming inadequate response in rheumatoid arthritis: weighing the evidence.
    Cohen SB; Cohen MD; Cush JJ; Fleischmann RM; Mease PJ; Schiff MH; Simon LS; Weaver AL
    J Rheumatol Suppl; 2008 Feb; 81():4-30; quiz 31-4. PubMed ID: 19193621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment and management of rheumatoid arthritis.
    Haraoui B
    J Rheumatol Suppl; 2009 Jun; 82():2-10. PubMed ID: 19509324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A potential pitfall in the use of the Disease Activity Score (DAS28) as the main response criterion in treatment guidelines for patients with rheumatoid arthritis.
    Gardiner PV; Bell AL; Taggart AJ; Wright G; Kee F; Smyth A; McKane R; Lee J; Rooney ME; Whitehead E
    Ann Rheum Dis; 2005 Mar; 64(3):506-7. PubMed ID: 15708909
    [No Abstract]   [Full Text] [Related]  

  • 11. The needle and the damage done.
    Franz JK; Burmester GR
    Ann Rheum Dis; 2005 Jun; 64(6):798-800. PubMed ID: 15897300
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anakinra in the treatment of rheumatoid arthritis].
    Loft AG; Tarp U; Thomsen BS
    Ugeskr Laeger; 2003 Sep; 165(39):3720-4. PubMed ID: 14558384
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of the Birmingham Rheumatoid Arthritis Model: past, present and future plans.
    Barton P
    Rheumatology (Oxford); 2011 Sep; 50 Suppl 4():iv32-iv38. PubMed ID: 21859704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shouldn't standard rheumatology clinical care be evidence-based rather than eminence-based, eloquence-based, or elegance-based?
    Pincus T; Tugwell P
    J Rheumatol; 2007 Jan; 34(1):1-4. PubMed ID: 17216670
    [No Abstract]   [Full Text] [Related]  

  • 15. Appropriate and effective management of rheumatoid arthritis.
    Breedveld FC; Kalden JR
    Ann Rheum Dis; 2004 Jun; 63(6):627-33. PubMed ID: 15140767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The case against haste in the treatment of rheumatoid arthritis: comment on the editorial by Pincus et al.
    Epstein WV
    Arthritis Rheum; 2003 Feb; 48(2):573-5; author reply 576-9. PubMed ID: 12571870
    [No Abstract]   [Full Text] [Related]  

  • 17. Unmet needs in rheumatoid arthritis.
    Bykerk V
    J Rheumatol Suppl; 2009 Jun; 82():42-6. PubMed ID: 19509330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Solution concerning the debate about Region Hovedstaden's guidelines for biological medicines in rheumatology].
    Lindberg M
    Ugeskr Laeger; 2010 Sep; 172(37):2555; author reply 2555. PubMed ID: 20862813
    [No Abstract]   [Full Text] [Related]  

  • 19. Early rheumatoid arthritis -- is there a window of opportunity?
    Cush JJ
    J Rheumatol Suppl; 2007 Nov; 80():1-7. PubMed ID: 17985417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs for rheumatoid arthritis.
    Treat Guidel Med Lett; 2009 May; 7(81):37-46; quiz 47-8. PubMed ID: 19390497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.